Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis

BACKGROUND: Most patients with autoimmune hepatitis respond to standard treatment with steroids and azathioprine. While the disease is usually fatal if untreated, patients who respond well to therapy have an excellent prognosis. Nevertheless, second-line treatment is necessary in approximately 20% o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolev, Mirjam, Diem, Stefan, Diem, Lara, Rodrigues, Susana G., Berzigotti, Annalisa, Stirnimann, Guido, Semmo, Nasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
VSI:Autoantibodies in disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702977/
https://www.ncbi.nlm.nih.gov/pubmed/36451933
http://dx.doi.org/10.1016/j.jtauto.2022.100172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702977/
https://www.ncbi.nlm.nih.gov/pubmed/36451933
http://dx.doi.org/10.1016/j.jtauto.2022.100172

Ejemplares similares